Literature DB >> 11468648

Pericarditis presenting and treated as an acute anteroseptal myocardial infarction.

K J Smith1, M Theal, A Mulji.   

Abstract

Early recognition and treatment of acute myocardial infarctions have been accepted as improving patient mortality. With the popular use of thrombolytic therapy, it is necessary to rule out contraindications and to consider other causes for ST segment elevation. A unique patient experiencing chest pain with marked and localized ST segment elevation in the anteroseptal leads is presented. He was treated with thrombolytic therapy. Subsequent investigations ruled out the diagnosis of myocardial infarction and confirmed the diagnosis of pericarditis. Although the patient's outcome was uncomplicated, physicians are urged to consider the diagnosis of pericarditis before using thrombolytic therapy to avoid life-threatening complications.

Entities:  

Mesh:

Year:  2001        PMID: 11468648

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  Prinzmetals Angina Masquerading as Acute Pericarditis.

Authors:  Ashwal Adamane Jayaram; Mugula Sudhakar Rao; R Padmakumar; Uk Abdul Razak
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Frequency and predictors of urgent coronary angiography in patients with acute pericarditis.

Authors:  Adam C Salisbury; Cristina Olalla-Gómez; Charanjit S Rihal; Malcolm R Bell; Henry H Ting; Grace Casaclang-Verzosa; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

3.  Regional Pericarditis Mimicking Inferior Myocardial Infarction following Abdominal Surgery.

Authors:  Ahmad T Alhammouri; Bassam A Omar
Journal:  Case Rep Med       Date:  2014-03-05

4.  Localised pericardial effusion mimicking anterior myocardial infarction following coronary angiography.

Authors:  Aynur Acibuca; Demet M Gerede; Veysel O Baris; Mustafa Kilickap
Journal:  Cardiovasc J Afr       Date:  2016-02-23       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.